Interim results from the ongoing Phase III ASSURE trial demonstrated that Livdelzi maintained a consistent biochemical ...

The use of RWD data in place of placebo groups is improving various elements across the clinical trial space.

In an effort to combat the state’s shortage of primary care physicians, Blue Cross Blue Shield of Massachusetts is offering ...

Country is poised to offer growth-channel opportunities for global pharma companies ready to scale access, innovation, and ...

Top-line results from two pivotal Phase III trials found that MR-107A-02 significantly reduced pain intensity following ...

Commissioner Markary announced the plans alongside the results of a generative AI pilot for scientific reviewers.

The idea of creating a gray zone in the payer message is to take the onus off of having to heavily discount for equal access ...

Founder and CEO of Alume Biosciences, Quyen Nguyen, MD, PhD, discusses nerve regeneration, nerve visualization and the reason behind what she does at Alume Biosciences.

The pharma tech company announced a deal with Starvision to roll out its services across the network over the next five years ...

The growing complexity of supply chains necessitates the adoption of collaborative planning processes and capabilities such ...

With this is mind, Abbott announced a new program that combines one of the most popular sports in the world with education ...

Results from the Phase III MYR301 trial show that 36% of patients who achieved undetectable hepatitis delta virus levels when ...